Kevin Noonan

Kevin Noonan is a partner at McDonnell Boehnen Hulbert & Berghoff, where he co-chairs the firm’s Biotechnology and Pharmaceuticals Practice Group.

He is a molecular biologist and experienced patent attorney who advises biotechnology and pharmaceutical companies on complex IP matters.

With over 30 years of experience, Kevin focuses on patent prosecution, interference proceedings, and patent litigation. He helps clients develop global patent strategies, assess litigation risks, and manage patent term extensions, and has represented clients in numerous high-stakes disputes, including amicus participation in landmark cases before US courts.